Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Fuji
Boehringer Ingelheim
AstraZeneca
Express Scripts
Julphar
Healthtrust
Argus Health

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,422,368

« Back to Dashboard

Summary for Patent: 5,422,368
Title: Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
Abstract:The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
Inventor(s): Stjernschantz; Johan W. (Upsala, SE), Resul; Bahram (Upsala, SE)
Assignee: Kabi Pharmacia AB (Upsala, SE)
Application Number:07/986,943
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,422,368
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 5,422,368

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,422,368

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8803110Sep 06, 1988
Sweden8803855Oct 28, 1988
PCT/SE89/00475Sep 06, 1989

International Family Members for US Patent 5,422,368

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 101342 ➤ Try a Free Trial
Austria 227576 ➤ Try a Free Trial
Austria 420857 ➤ Try a Free Trial
Australia 4189889 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Accenture
Baxter
Medtronic
Harvard Business School
UBS
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.